Crystal's Coder Hub🫁 CPT 31536 — Laryngoscopy, Direct, Operative, With Biopsy; With Operating Microscope or Telescope
Quick Reference
wRVU: 3.41 | Global Period: 010 (10 days) | Assistant Payable: ✅ Yes | Bilateral Indicator: 0
📋 Clinical Description
CPT 31536 describes a direct operative laryngoscopy with biopsy performed using an operating microscope or telescope — commonly referred to as microlaryngoscopy with biopsy. The procedure requires: (1) the patient supine under general anesthesia with the neck extended in the “sniffing position”; (2) a rigid suspension laryngoscope (Dedo, Lindholm, Parsons, or equivalent) introduced transorally and suspended on a chest support to provide stable, hands-free laryngeal exposure; (3) visualization achieved via either an operating microscope (typically ×6-×16 magnification; provides stereoscopic three-dimensional view — the classic microlaryngoscopy technique) or a rigid telescope (0°, 30°, or 70° Hopkins rod-lens endoscope providing a high-resolution image on a monitor); and (4) a biopsy performed using microlaryngeal cup forceps, Blakesley forceps, microscissors, CO2 laser, or powered microdebrider to obtain tissue sample(s) for pathologic examination.
The critical distinction between 31535 and 31536 is solely the presence of the operating microscope or telescope: 31535 is the same procedure without magnification. Per the AAPC Otolaryngology Coding Alert (March 2014), 31536 requires that a biopsy actually be obtained — if the surgeon uses the microscope for examination but does not take a biopsy, the correct code is 31526 (direct laryngoscopy, diagnostic, with operating microscope or telescope), not [[31536]]. The operative note must explicitly document: (1) use of the operating microscope or telescope by name, AND (2) biopsy performed with tissue sent to pathology. Both elements are mandatory — absence of either requires a different code.
CPT 31536 carries a 10-day global period, reflecting the diagnostic nature of the biopsy. The post-biopsy healing course is expected to be brief, but the 10-day global means that planned staged therapeutic procedures (e.g., CO2 laser resection of a biopsied tumor after pathology returns) performed within 10 days require modifier -58 with documentation of planned staging in the original operative report.
This procedure may be performed in the following clinical contexts:
- Evaluation and biopsy of suspected laryngeal malignancy — The most common indication; a lesion suspicious for carcinoma (leukoplakia, erythroplakia, exophytic mass, ulceration) identified on office flexible laryngoscopy is biopsied under microlaryngoscopy for histopathologic diagnosis and clinical staging; document the lesion location (glottis, supraglottis, subglottis), size, and endoscopic characteristics.
- Biopsy of vocal cord lesion requiring tissue diagnosis — When the nature of a vocal cord lesion cannot be confirmed clinically and tissue diagnosis is required before planned surgical treatment; microlaryngoscopy allows precise high-magnification sampling at the lesion margin; document the lesion type, location (right vs. left vocal cord, anterior/mid/posterior third), and biopsy technique.
- Staging panendoscopy with laryngeal biopsy — In head and neck oncology, direct laryngoscopy with biopsy is performed as part of panendoscopy (direct laryngoscopy + esophagoscopy + bronchoscopy) to biopsy the primary site, evaluate for synchronous second primaries, and assess submucosal spread; 31536 captures the laryngoscopy-with-biopsy component; esophagoscopy and bronchoscopy are separately coded.
- Post-treatment surveillance biopsy — In patients with a history of laryngeal carcinoma treated with radiation, chemoradiation, or prior endoscopic surgery, mucosal changes on follow-up flexible laryngoscopy may require biopsy to distinguish fibrosis/radiation change from recurrence; document prior treatment history and the specific mucosal changes prompting the biopsy.
- Evaluation of subglottic or posterior laryngeal lesion — Lesions in the subglottis or posterior larynx require rigid suspension microlaryngoscopy for adequate access and magnification not achievable with office-based flexible laryngoscopy; microlaryngoscopy with biopsy provides both access and high-resolution visualization.
- Unknown primary tumor workup with suspected laryngeal primary — When a patient presents with cervical lymphadenopathy and no obvious primary on examination, panendoscopy with directed biopsies of the larynx, tongue base, pyriform sinuses, and nasopharynx is performed; 31536 captures the laryngeal biopsy component.
🔬 Key Code Distinctions — Direct Laryngoscopy with Biopsy Family
| Code | Descriptor | Microscope/Telescope | Biopsy Required | Global | wRVU |
|---|---|---|---|---|---|
| 31525 | Laryngoscopy, direct, diagnostic | ❌ No | ❌ No | 000 | ~1.39 |
| 31526 | Laryngoscopy, direct, diagnostic; with operating microscope or telescope | ✅ Yes | ❌ No | 000 | ~1.90 |
| 31535 | Laryngoscopy, direct, operative, with biopsy | ❌ No | ✅ Yes | 010 | ~2.58 |
| 31536 | Laryngoscopy, direct, operative, with biopsy; with operating microscope or telescope | ✅ Yes — required | ✅ Yes — required | 010 | 3.41 |
Two Mandatory Documentation Elements for 31536
Per AAPC Otolaryngology Coding Alert (March 2014), 31536 requires BOTH of the following documented in the operative report:
Operating microscope OR rigid telescope was used — the specific instrument must be named in the operative note (e.g., “Zeiss operating microscope,” “0° Hopkins rod telescope,” “Storz telescope”)
A biopsy was obtained — tissue was excised and submitted to pathology; merely placing biopsy instruments without obtaining tissue does NOT qualify
- Microscope/telescope used but NO biopsy taken → 31526
- Biopsy taken but NO microscope/telescope used → 31535
- Neither microscope nor biopsy → 31525
Failure to document both elements in the operative note is the primary audit vulnerability for 31536 claims.
✅ Procedure Includes
- Pre-operative flexible laryngoscopy correlation (bundled when performed same day by the same provider)
- General anesthesia (separately billable by the anesthesia provider under CPT 00320 for patients ≥ 1 year)
- Suspension laryngoscopy setup — rigid laryngoscope placement, suspension on chest/Mayo stand support, verification of adequate glottic exposure
- Operating microscope setup and focusing OR telescope introduction with camera/monitor system
- Thorough magnified inspection of all laryngeal structures — supraglottis, glottis, subglottis, and adjacent hypopharynx
- Biopsy — cup forceps, laser, or other instrument excision of tissue from the target lesion(s)
- Specimen handling — fixative, labeling, send-out to pathology (bundled)
- Intraoperative hemostasis (cautery, epinephrine, laser coagulation) — bundled
- Post-procedure airway assessment, laryngoscope removal, and extubation
❌ Excludes / Do Not Report Together
| Code | Description | Relationship to 31536 |
|---|---|---|
| 31526 | Laryngoscopy, direct, diagnostic, with operating microscope or telescope | Mutually exclusive with 31536 for the same session — 31526 is diagnostic-only (no biopsy); 31536 adds the biopsy; when a biopsy IS performed, 31536 is correct; never report both codes for the same laryngoscopy session |
| 31535 | Laryngoscopy, direct, operative, with biopsy | Mutually exclusive with 31536 for the same session — 31535 is biopsy without microscope; 31536 is biopsy WITH microscope; report the correct code based on whether magnification was used; do NOT report both together |
| 31540 | Laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis | Potentially separately reportable when tumor excision AND a biopsy of a distinct laryngeal site are performed at the same session; operative note must document each as a distinct, separately performed procedure with independent clinical rationale; confirm NCCI edit status before reporting both |
| 31541 | Laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis; with operating microscope or telescope | Same relationship as 31540 — 31541 adds the microscope/telescope; confirm NCCI edits before reporting alongside 31536 for the same session |
| 31545 | Laryngoscopy, direct, operative, with operating microscope or telescope, with submucosal removal of non-neoplastic lesion(s) of vocal cord | Separately reportable when submucosal lesion removal AND a biopsy of a distinct laryngeal site are performed at the same session; 31545 is unilateral — may be reported bilaterally; document each service with distinct anatomic sites |
| 31571 | Laryngoscopy, direct, operative, with injection(s) for augmentation; with operating microscope or telescope | Separately reportable when laryngeal injection AND biopsy are performed at the same session as distinct procedures with distinct indications; apply modifier -51 to the lower-valued code; document each separately |
| 88305 | Level IV — Surgical pathology, gross and microscopic examination | Pathology processing and interpretation of the biopsy specimen is separately billable by the pathologist/pathology department — NOT by the surgeon; the surgeon bills 31536 for the procedure; the pathologist bills 88305 (or 88302 for very small biopsies) for specimen interpretation; do not confuse surgical and pathology billing streams |
| E/M codes (992xx / 920xx) | Office or hospital visit, any level | Separately reportable with modifier -25 on the E/M code — NOT on 31536 — when a significant, separately identifiable evaluation is performed same date; with the 10-day global, same-day E/M services are bundled unless -25 is applied to the E/M code |
Global Period is 010 (10 days) — Not 90 Days
CPT 31536 carries a 10-day global period — significantly shorter than the 90-day global of most surgical procedures, reflecting the diagnostic nature of the biopsy. Key implications:
- Post-operative visits within 10 days for routine healing (sore throat, transient hoarseness, wound check) are bundled and not separately billable
- When a planned staged therapeutic procedure (e.g., CO2 laser resection after pathology confirms malignancy) is performed within the 10-day window, modifier -58 is required on the second procedure code — the planned staging must be documented in the original 31536 operative report
- Unrelated procedures within the 10-day global require modifier -79
- Unrelated E/M visits within the 10-day global require modifier -24 on the E/M code (NOT on 31536)
🌳 Code Tree — Surgery: Respiratory System — Operative Laryngoscopy Family
CPT 31505-31579 Endoscopy Procedures on the Larynx
│
DIAGNOSTIC LARYNGOSCOPY:
├── 31505 Laryngoscopy, indirect; diagnostic (separate procedure) (Global: 000)
├── 31510 Laryngoscopy, indirect, with biopsy (Global: 000)
├── 31520 Laryngoscopy, direct, diagnostic, newborn (Global: 000)
├── 31525 Laryngoscopy, direct, with or without tracheoscopy; diagnostic (Global: 000)
└── 31526 Laryngoscopy, direct, with or without tracheoscopy; diagnostic, with operating microscope or telescope (Global: 000)
│
OPERATIVE LARYNGOSCOPY — BIOPSY:
├── 31535 Laryngoscopy, direct, operative, with biopsy (Global: 010)
└── ▶▶ 31536 ◀◀ Laryngoscopy, direct, operative, with biopsy; with operating microscope or telescope ← YOU ARE HERE (Global: 010)
│
OPERATIVE LARYNGOSCOPY — EXCISION / SURGICAL:
├── 31540 Laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis (Global: 090)
├── 31541 Laryngoscopy, direct, operative, with excision of tumor and/or stripping of vocal cords or epiglottis; with operating microscope or telescope (Global: 090)
├── 31545 Laryngoscopy, direct, operative, with operating microscope or telescope, with submucosal removal of non-neoplastic lesion(s) of vocal cord (Global: 090) ← UNILATERAL
├── 31546 Laryngoscopy, direct, operative, with operating microscope or telescope, with submucosal removal of non-neoplastic lesion(s) of vocal cord; reconstruction with graft(s) (Global: 090) ← UNILATERAL
├── 31560 Laryngoscopy, direct, operative, with arytenoidectomy (Global: 090)
├── 31561 Laryngoscopy, direct, operative, with arytenoidectomy; with operating microscope or telescope (Global: 090)
├── 31571 Laryngoscopy, direct, operative, with injection(s) for augmentation; with operating microscope or telescope (Global: 010)
└── 31572 Laryngoscopy, direct, operative, with ablation or destruction of lesion(s) using a photosensitizing drug (Global: 010)
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 3.41 (CMS RVU26A; verify against current MPFS for applicable year; subject to 2026 efficiency adjustment) |
| Non-Facility PE RVU | ~5.69 (verify against CMS RVU26A) |
| Malpractice RVU | ~0.37 |
| Non-Facility Total RVU | ~9.47 (verify against CMS RVU26A) |
| Facility Total RVU | ~5.68 (verify against CMS RVU26A; most 31536 claims are facility-based — outpatient hospital or ASC) |
| Estimated Medicare Facility Payment (2026) | ~33.4009 × facility total RVU; actual payment varies by locality GPCI — verify)* |
| National Average Commercial Rate (2026) | ~353 (per PayerPrice 2025 payer data; verify per specific payer contract) |
| Global Period | 010 (10 days) |
| Bilateral Indicator | 0 — Not a bilateral procedure; the larynx is a single structure; biopsies may be taken from both vocal cords or multiple laryngeal subunits at the same session, but 31536 is reported once for the session; modifier -50 is never appropriate for 31536 |
| Assistant Surgeon | ✅ Payable — modifier -80 or -82; document medical necessity; appropriate for complex oncologic staging panendoscopy cases or patients with anticipated difficult airway |
| Co-Surgeon | ✅ Applicable in panendoscopy — modifier -62 when two surgeons of different specialties simultaneously perform distinct non-overlapping procedures (e.g., ENT performs laryngoscopy while another surgeon concurrently performs bronchoscopy); each surgeon bills their own code |
| PC/TC Split | ❌ No — Procedure code only (Indicator 0) |
| Modifier -51 Exempt | No — Subject to multiple procedure reduction rules when billed with other surgical procedures at the same session |
| Anesthesia | General anesthesia required — oral RAE endotracheal tube or jet ventilation; separately billable by the anesthesia provider under CPT 00320 (anesthesia for all procedures on larynx and trachea, patients ≥ 1 year) or CPT 00326 (anesthesia for all procedures on larynx/trachea, patient < 1 year, except endoscopy) |
31536 vs. 31535: The Microscope/Telescope wRVU Premium
The operating microscope or telescope adds approximately 0.83 wRVU over 31535 (from ~2.58 to 3.41 wRVU) — reflecting the additional setup time, technical precision, and enhanced visualization quality that microlaryngoscopy provides. In academic and tertiary laryngology practices, the operating microscope or telescope is standard of care for virtually all operative laryngoscopies with biopsy. However, some community ENT settings may perform direct laryngoscopy with biopsy using only headlight and/or loupes — those cases code to 31535. Accurate documentation of the visualization instrument used is a financially meaningful documentation education priority, with the differential representing real revenue per case.
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -22 | Increased Procedural Services | When microlaryngoscopy required substantially greater work than typical — extremely difficult laryngoscopic exposure (short neck, large tongue, limited jaw opening from prior radiation or scarring), bulky tumor requiring multiple biopsy passes, post-radiation fibrotic mucosa complicating tissue acquisition, significantly extended operative time; operative note must document specific complexity factors; attach a cover letter to the claim |
| -25 | Significant, Separately Identifiable E/M | Applied to the E/M code — NOT 31536 — when a significant, separately identifiable evaluation is performed same date; the 10-day global bundles same-day E/M unless -25 is applied to the E/M code |
| -51 | Multiple Procedures | When 31536 is performed alongside other separately reportable surgical procedures at the same session — e.g., concurrent 31571 (laryngeal injection augmentation), 31560 (arytenoidectomy), esophagoscopy, or bronchoscopy; apply -51 to the lower-valued procedure code |
| -52 | Reduced Services | Procedure partially completed — e.g., laryngoscopic exposure obtained but biopsy limited in scope due to patient condition or anatomic constraints; document the specific circumstances; if NO biopsy was obtained at all, 31526 is the more appropriate code rather than 31536--52 |
| -53 | Discontinued Procedure | Procedure started but discontinued before biopsy was obtained — e.g., cannot-intubate scenario, desaturation, cardiac event during induction; document the specific reason for discontinuation; if laryngoscopy was performed but biopsy was not obtained, evaluate 31526 or 31525 rather than 31536--53 |
| -58 | Staged or Related Procedure | Most critical modifier for 31536 in oncologic practice — used when a planned staged therapeutic procedure (e.g., CO2 laser resection after pathology confirms malignancy, planned neck dissection after biopsy-confirmed laryngeal carcinoma) is performed within the 10-day global window; must be documented as planned in the original 31536 operative report (“If pathology confirms carcinoma, plan to return for laser resection within 2 weeks”); opens a new global period for the staged procedure |
| -59 | Distinct Procedural Service | When 31536 is billed alongside another procedure that payers may bundle; documents a genuinely distinct service at a distinct anatomic site or separate encounter; use when the biopsy is at a clearly different anatomic location from a concurrent procedure |
| -XS | Separate Structure | Preferred over -59 when the distinct service involves a clearly separate anatomic structure — e.g., 31536 alongside 43191 (rigid esophagoscopy with biopsy) or 31622 (bronchoscopy) in panendoscopy; each procedure is at a distinct anatomic structure and XS documents that distinction |
| -62 | Two Surgeons | When two surgeons of different specialties perform distinct, non-overlapping portions simultaneously — e.g., ENT performs laryngoscopy while a thoracic surgeon performs concurrent bronchoscopy; each surgeon bills their own code with -62 when both contribute to a single coordinated procedure; when procedures are fully independent and non-overlapping, each surgeon typically bills without -62 |
| -54 | Surgical Care Only | Surgeon performs the microlaryngoscopy with biopsy but post-operative care is transferred to another provider; the 10-day global is split between providers |
| -55 | Postoperative Management Only | Provider assuming post-operative care during the 10-day global after surgery was performed by a different surgeon |
| -76 | Repeat Procedure by Same Physician | Repeat microlaryngoscopy with biopsy by the same surgeon — e.g., recurrent lesion requiring re-biopsy, post-treatment biopsy to confirm complete response; document specific clinical indication for the repeat procedure |
| -77 | Repeat Procedure by Different Physician | Repeat procedure by a different surgeon |
| -78 | Unplanned Return to OR | Unplanned return during the 10-day global — e.g., post-biopsy laryngeal hemorrhage requiring OR intervention; document the unplanned nature and the complication driving the return |
| -79 | Unrelated Procedure During Postoperative Period | Unrelated surgical procedure performed during the 10-day global window; document the unrelated clinical indication |
| -80 | Assistant Surgeon | When an assistant surgeon participates — document medical necessity; appropriate for complex oncologic staging panendoscopy or anticipated difficult airway management |
Modifiers NOT Used with 31536
- -50 — NEVER appropriate; the larynx is a single midline structure; biopsies from both vocal cords at the same session are still one 31536 — no bilateral modifier applies
- -57 — Not applicable; -57 (decision for major surgery) applies to procedures with a 90-day global period; 31536 has a 010 global; the decision-for-surgery modifier does not apply to 10-day global codes
🩺 Common ICD-10-CM Pairings
Laryngeal Malignancy — Primary Diagnoses
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| C32.0 | Malignant neoplasm of glottis | ✅ HCC | Use when the biopsied lesion is on the glottis — true vocal cords, anterior commissure, posterior commissure; the most common location for laryngeal SCC; confirm from pathology and operative note that the lesion is glottic; document clinical T stage |
| C32.1 | Malignant neoplasm of supraglottis | ✅ HCC | Use when the biopsied lesion is in the supraglottis — epiglottis (laryngeal surface), aryepiglottic folds (laryngeal aspect), false vocal cords, arytenoids, or laryngeal ventricles; document the specific supraglottic subunit from the operative note and biopsy report |
| C32.2 | Malignant neoplasm of subglottis | ✅ HCC | Use when the biopsied lesion is in the subglottis — below the true vocal cords to the inferior margin of the cricoid cartilage; subglottic primaries are rare but clinically aggressive; document endoscopic and pathologic localization to the subglottis |
| C32.8 | Malignant neoplasm of overlapping sites of larynx | ✅ HCC | Use when the tumor overlaps two or more laryngeal subsites (e.g., transglottic tumor involving glottis and supraglottis) and cannot be assigned to a single subsite; confirm overlap from the operative description and pathology findings |
| C32.9 | Malignant neoplasm of larynx, unspecified | ✅ HCC | Use only when the operative note and pathology report cannot specify the laryngeal subsite — this is a true fallback code; query the surgeon for subsite specificity before assigning unspecified; the four subsite-specific codes above are always preferred |
Benign and Pre-Malignant Laryngeal Lesions
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| D14.1 | Benign neoplasm of larynx | ❌ No | Use for confirmed or suspected benign laryngeal neoplasms — papilloma, fibroma, hemangioma, chondroma — when biopsy is performed for tissue characterization; confirm benign nature from pathology; do NOT assign benign neoplasm code if malignancy is suspected and not yet excluded — use the clinical finding/symptom code pending pathology |
| J38.1 | Polyp of vocal cord and larynx | ❌ No | Use when a vocal cord or laryngeal polyp is the lesion being biopsied for tissue diagnosis; note that most polyp removal is coded as 31545 or 31541 (surgical removal); when the operative note specifically describes biopsy rather than complete removal, 31536 + J38.1 is appropriate |
| J38.2 | Nodules of vocal cords | ❌ No | Use for vocal cord nodules being biopsied to exclude malignancy in an unusual-appearing nodule; most nodules are diagnosed clinically without biopsy, so this pairing is uncommon; document why tissue diagnosis was clinically indicated rather than clinical diagnosis alone |
| J38.3 | Other diseases of vocal cords | ❌ No | Use for vocal cord leukoplakia, vocal cord dysplasia, hyperkeratosis, or Reinke’s edema requiring biopsy for pathologic characterization; J38.3 does not distinguish between specific conditions — document the specific clinical finding in the medical record even when ICD-10-CM resolution is limited |
Functional and Structural Laryngeal Disorders
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| J38.6 | Stenosis of larynx | ❌ No | Use when microlaryngoscopy with biopsy is performed to evaluate tissue at a site of laryngeal stenosis (subglottic stenosis, glottic stenosis) to confirm fibrotic versus neoplastic etiology; document stenosis location, degree, and the specific tissue change driving the biopsy decision |
| J38.7 | Other diseases of larynx | ❌ No | Broad catch-all for laryngeal pathology not covered by more specific codes — laryngeal granuloma, laryngeal ulceration, post-intubation laryngeal changes, laryngeal edema with unclear etiology; use the most specific code available; default to J38.7 only when no specific code applies |
| J38.01 | Paralysis of vocal cords and larynx, unilateral | ❌ No | Use when microlaryngoscopy with biopsy is performed to evaluate a new unilateral vocal cord paralysis and a concurrent mucosal lesion must be excluded; the biopsy addresses a lesion identified during the laryngoscopy; document both the paralysis and the biopsied lesion findings in the operative note |
| R49.0 | Dysphonia | ❌ No | Use as primary or secondary diagnosis when dysphonia is the presenting symptom driving the microlaryngoscopy with biopsy — typically when a lesion suspicious for malignancy is identified on office laryngoscopy in a patient presenting with voice change; R49.0 supports medical necessity for the procedure; assign as secondary when a more specific diagnosis (e.g., J38.3, C32.0) is available |
Post-Treatment / Surveillance
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| Z85.21 | Personal history of malignant neoplasm of larynx | ❌ No | Use as primary or secondary diagnosis when microlaryngoscopy with biopsy is performed for surveillance of a patient with a prior history of laryngeal carcinoma — post-treatment recurrence monitoring; document the specific mucosal change prompting the surveillance biopsy; if recurrence is confirmed on the biopsy, replace Z85.21 with the appropriate active malignancy code (C32.0, C32.1, etc.) when pathology returns |
ICD-10-CM Coding Timing Rule for Malignancy — Pathology Pending vs. Confirmed
When 31536 is performed to biopsy a suspected malignant lesion and pathology results are not yet available at the time of coding, do NOT assign a confirmed malignancy code (C32.0, C32.1, etc.). Per ICD-10-CM Official Coding Guidelines Section I.C.2: code the condition to the highest degree of certainty — use the sign or symptom code (R49.0 dysphonia, J38.3 leukoplakia/other vocal cord disease) or, if a mass is documented, the uncertain behavior neoplasm code from the D37-D44 range if appropriate. Once pathology returns and confirms malignancy, the medical record is updated and the confirmed malignancy code is assigned. For outpatient profee coding, this distinction is particularly important — outpatient guidelines prohibit coding “probable” or “suspected” diagnoses as confirmed.
🏥 MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 31536 is performed almost exclusively in the outpatient hospital or ASC setting. Inpatient admission for isolated microlaryngoscopy with biopsy is clinically uncommon and typically not supported by utilization review criteria. When performed during an inpatient admission for a concurrent diagnosis (e.g., staging panendoscopy in a patient admitted for nutritional optimization before planned chemoradiation, or concurrent head and neck oncology workup with neck dissection), the ICD-10-PCS procedure code is required for facility coding. The PCS code is assigned in addition to the PCS codes for any concurrent inpatient procedures. At the profee level, 31536 is reported by the otolaryngologist regardless of the place of service. The inpatient DRG is driven by the principal diagnosis — laryngeal malignancy diagnoses (C32.0-C32.9) group to MDC 03 head and neck DRGs with higher base weights; confirm with your facility’s DRG grouper for the specific DRG assignment based on concurrent CC/MCC diagnoses and procedures.
🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)
Note
At the inpatient facility level, 31536 is represented by ICD-10-PCS root operation Excision (B) — cutting out or off, without replacement, a portion of a body part — with qualifier X (Diagnostic) indicating the tissue is removed for biopsy/diagnosis rather than for therapeutic removal. This is the PCS-defining characteristic that distinguishes a biopsy (Excision with qualifier X = Diagnostic) from a therapeutic excision (Excision with qualifier Z = No Qualifier). The body part character is selected based on the specific laryngeal subunit biopsied: Larynx (C), Epiglottis (S), Vocal Cord Right (P), or Vocal Cord Left (Q). The approach for direct suspension microlaryngoscopy is Percutaneous Endoscopic (4) — instrumentation introduced through the natural oral cavity with endoscopic visualization — or Via Natural or Artificial Opening Endoscopic (8) depending on approach documentation.
| PCS Code | Full Description | Applicable Scenario |
|---|---|---|
0CBC4ZX | Excision of Larynx, Percutaneous Endoscopic Approach, No Device, Diagnostic | Biopsy of laryngeal tissue (non-specific subunit) — use when the biopsied structure is the larynx broadly and a more specific body part character is not available or appropriate |
0CBC8ZX | Excision of Larynx, Via Natural or Artificial Opening Endoscopic, No Device, Diagnostic | Same as above — Via Natural or Artificial Opening Endoscopic approach |
0CBF4ZX | Excision of Epiglottis, Percutaneous Endoscopic Approach, No Device, Diagnostic | Biopsy of the epiglottis specifically |
0CBP4ZX | Excision of Vocal Cord, Right, Percutaneous Endoscopic Approach, No Device, Diagnostic | Biopsy of the right vocal cord |
0CBQ4ZX | Excision of Vocal Cord, Left, Percutaneous Endoscopic Approach, No Device, Diagnostic | Biopsy of the left vocal cord |
PCS Character Analysis — 0CBP4ZX (Right Vocal Cord Biopsy via Microlaryngoscopy)
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | C | Mouth and Throat |
| 3 | Root Operation | B | Excision (cutting out or off, without replacement, a portion of a body part — in this context, tissue is excised and submitted for pathologic examination) |
| 4 | Body Part | P | Vocal Cord, Right |
| 5 | Approach | 4 | Percutaneous Endoscopic (instrumentation introduced through the skin or mucous membrane and body layers to reach the procedure site — the suspension laryngoscope provides the endoscopic access through the oral cavity to the larynx) |
| 6 | Device | Z | No Device |
| 7 | Qualifier | X | Diagnostic — critical qualifier identifying this as a biopsy (tissue removed for diagnosis); distinguishes from therapeutic excision (qualifier Z = No Qualifier) |
PCS Qualifier X (Diagnostic) Is Non-Negotiable for Biopsies
Per ICD-10-PCS Guidelines Section B3.4a: “Biopsy procedures are coded using the root operations Excision, Extraction, or Drainage and the qualifier Diagnostic.” For all 31536 biopsy cases:
- Qualifier X (Diagnostic) = biopsy; tissue removed solely or primarily to establish a diagnosis
- Qualifier Z (No Qualifier) = therapeutic excision; tissue removed to treat the condition
- When the surgeon removes tissue both to diagnose AND to treat (e.g., removes the entire visible lesion and sends it to pathology), PCS Guideline B3.4b applies: if both a biopsy and a more definitive treatment are performed on the same site during the same surgical event, only the code for the more definitive treatment is assigned — which would be qualifier Z (therapeutic); qualifier X applies when the excision is solely for diagnostic purposes
📝 Coding Examples
Example 1 — ASC: Microlaryngoscopy with Biopsy for Vocal Cord Leukoplakia
Clinical Scenario: A 58-year-old male, active smoker with a 40-pack-year history, presents with a 5-month history of persistent hoarseness. Office strobovideolaryngoscopy demonstrates a raised white plaque (leukoplakia) on the anterior third of the right true vocal cord with irregular surface and a focal area of erythroplakia raising concern for early malignancy. The otolaryngologist schedules direct microlaryngoscopy for biopsy. Under general anesthesia with an oral RAE tube, a Dedo laryngoscope is placed and suspended. The Zeiss operating microscope is brought in and focused at ×10 magnification. The right vocal cord leukoplakia is identified — irregular, raised, approximately 5mm in greatest dimension, involving the superior surface of the right true vocal cord, anterior third. Cold steel microlaryngeal cup forceps are used to obtain two tissue samples from the lesion. Specimens are placed in formalin and labeled “right true vocal cord biopsy x2.” The surgeon documents: “Zeiss operating microscope used throughout; right vocal cord leukoplakia biopsied with microlaryngeal cup forceps; specimens sent to pathology.”
| Field | Code | Rationale |
|---|---|---|
| CPT | 31536 | Direct operative laryngoscopy with biopsy, with operating microscope — both mandatory elements explicitly documented: Zeiss operating microscope named, biopsy obtained and sent to pathology; right true vocal cord leukoplakia biopsied |
| PDx | J38.3 | Other diseases of vocal cords — vocal cord leukoplakia is the clinically documented finding; malignancy is suspected but NOT confirmed pending pathology; per outpatient ICD-10-CM guidelines, do NOT code C32.0 (malignant neoplasm of glottis) until pathology confirms; J38.3 is the most appropriate code for leukoplakia |
| SDx | R49.0 | Dysphonia — persistent hoarseness is a documented secondary symptom supporting medical necessity |
| SDx | F17.210 | Nicotine dependence, cigarettes, uncomplicated — active smoking history documented; relevant to medical necessity and disease etiology |
Note
Once pathology results return — if confirming squamous cell carcinoma of the right true vocal cord (glottis) — the coding for that subsequent encounter (e.g., the office visit to discuss results, the return OR for laser resection) changes to C32.0 (malignant neoplasm of glottis). The 31536 biopsy encounter itself is coded to J38.3 per outpatient guidelines since the malignancy was not confirmed at the time of the procedure. If the 31536 encounter is coded after pathology returns (i.e., the claim is not submitted until after confirmation), some facilities may code the confirmed diagnosis — verify your payer’s policies and your facility’s coding guidelines for timing of diagnosis confirmation in outpatient surgical claims.
Example 2 — Outpatient Hospital: Panendoscopy with Laryngeal Biopsy — Unknown Primary
Clinical Scenario: A 63-year-old female with a 2.5 cm right level II cervical lymph node on CT imaging, FNA showing squamous cell carcinoma, presents for panendoscopy under general anesthesia to identify the primary tumor site. Under general anesthesia with a flexible nasopharyngoscope for nasopharyngeal evaluation, then Dedo laryngoscope suspension with 0° Hopkins rod telescope for direct laryngoscopy, then rigid esophagoscopy. During direct laryngoscopy with 0° telescope, a subtle area of mucosal irregularity is identified on the right aryepiglottic fold; biopsy is obtained with microlaryngeal cup forceps. Rigid esophagoscopy with biopsy of suspicious areas in the post-cricoid region is separately performed. The operative note documents each procedure distinctly with separate instrument descriptions and biopsy sites.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 31536 | Direct operative laryngoscopy with biopsy, with telescope (0° Hopkins rod telescope explicitly documented); biopsy of right aryepiglottic fold mucosal irregularity obtained |
| CPT 2 | 43191--51 | Rigid esophagoscopy, diagnostic — or 43197 if flexible; separately reportable as a distinct procedure at a distinct anatomic site (esophagus/post-cricoid); -51 on the lower-valued code; confirm correct esophagoscopy code based on instrument used (rigid vs. flexible) and services performed |
| PDx | C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck — the FNA-confirmed metastatic SCC in the cervical lymph node is the principal diagnosis driving the panendoscopy; the primary site is unknown at the time of the procedure |
| SDx | C80.1 | Malignant (primary) neoplasm, unspecified — code for the unknown primary site in the setting of metastatic SCC of unknown primary; assign pending primary site identification |
Warning
When billing multiple procedures from a panendoscopy, each procedure must be separately documented in the operative note with its own instrument, approach, findings, and biopsy sites clearly described. Payers may scrutinize panendoscopy claims for NCCI bundling — confirm modifier -59 or XS requirements for each code pair based on the current NCCI edit table. The esophagoscopy and laryngoscopy are at genuinely distinct anatomic structures, supporting separate reportability with XS (separate structure) on the secondary code rather than -59.
Example 3 — Outpatient Hospital: Microlaryngoscopy with Biopsy — Surveillance After Radiation, Staged Resection Planned
Clinical Scenario: A 66-year-old male with a history of T2N0 squamous cell carcinoma of the left true vocal cord (glottis) treated with definitive radiation 14 months ago presents with new-onset hoarseness and an area of mucosal thickening on the left true vocal cord on office stroboscopy. Microlaryngoscopy with biopsy is performed using the Zeiss operating microscope. Left true vocal cord mucosal thickening biopsied — two specimens sent to pathology. The operative note documents: “Zeiss operating microscope used; biopsy of left true vocal cord mucosal thickening via cold steel cup forceps; specimens sent to pathology. If pathology confirms recurrent carcinoma, plan to return for CO2 laser resection within 2 weeks.”
| Field | Code | Rationale |
|---|---|---|
| CPT | 31536 | Direct operative laryngoscopy with biopsy, with operating microscope — Zeiss microscope documented, biopsy obtained; staged resection documented as planned in operative note |
| PDx | Z85.21 | Personal history of malignant neoplasm of larynx — the biopsy is a surveillance procedure in a patient with prior laryngeal carcinoma; malignancy is suspected but NOT confirmed at the time of coding; Z85.21 as primary diagnosis with the mucosal finding as secondary; once pathology returns confirming recurrence, subsequent encounter coding changes to active malignancy |
| SDx | J38.3 | Other diseases of vocal cords — mucosal thickening of the vocal cord is the documented finding; not yet confirmed as malignant at time of this encounter |
| SDx | R49.0 | Dysphonia — new hoarseness is documented as the presenting symptom |
Note
The staged resection modifier planning is critical here. The operative note explicitly documents “plan to return for CO2 laser resection within 2 weeks” — this language establishes the planned staging for modifier -58 purposes. When the patient returns within the 10-day global window for CO2 laser resection (31541 — direct operative laryngoscopy with excision of tumor, with operating microscope), modifier -58** is appended to 31541 to indicate a staged, planned procedure within the global of 31536. Without this documentation in the original operative note, the return OR visit within 10 days could be challenged as unbundling or a duplicate service. Coders should educate surgeons performing surveillance microlaryngoscopy in oncology patients to routinely document the planned staging language in their operative notes.
⚠️ Common Coding Pitfalls
-
Reporting 31536 when the operating microscope or telescope was not documented: 31536 and its ~0.83 wRVU premium over 31535 depend entirely on documentation that the microscope or telescope was used. If the operative note does not name the microscope or telescope (e.g., notes only “direct laryngoscopy with biopsy” without specifying the visualization instrument), the correct code is 31535 — not 31536. Coders should not infer that the microscope was used based on the setting (academic center, laryngology subspecialty) without explicit documentation. Provider education should include templated operative note language that names the visualization instrument in every microlaryngoscopy case.
-
Coding a confirmed malignancy before pathology results are available (outpatient): Per ICD-10-CM outpatient guidelines, diagnoses documented as “suspected,” “probable,” or “rule out” are NOT coded as confirmed in the outpatient setting. When 31536 is performed to biopsy a lesion suspicious for carcinoma and pathology is pending, the correct ICD-10-CM code is the sign/symptom or the most specific mucosal finding (J38.3 for leukoplakia/dysplasia, R49.0 for dysphonia) — NOT C32.0 or other malignancy codes. Premature malignancy coding can affect claims, HCC risk scores, and patient records incorrectly. Once pathology confirms the diagnosis, the subsequent encounter is coded to the confirmed malignancy.
-
Failing to apply modifier -58 for a planned staged resection within the 10-day global: The 10-day global for 31536 is short enough that a planned staged therapeutic procedure (CO2 laser resection after biopsy confirms malignancy) may fall within the global window. Without modifier -58 on the staged therapeutic procedure code, the second procedure claim will be denied or automatically bundled into 31536. The planning documentation in the original operative report is the foundation for the -58 claim — if the operative note does not state the staging intent, the -58 modifier cannot be defended on audit.
-
Reporting 31536 when no biopsy was obtained: If the surgeon performed direct suspension microlaryngoscopy with the operating microscope or telescope but did not obtain a biopsy (e.g., the lesion appeared benign on visualization and no tissue was taken, or the biopsy was deferred), the correct code is 31526 (direct laryngoscopy, diagnostic, with operating microscope or telescope) — not 31536. Per AAPC Otolaryngology Coding Alert (March 2014), 31536 requires that tissue be taken and sent to pathology. Reporting 31536 when only visualization occurred overstates the service and is incorrect coding.
-
Using -51 and -50 incorrectly with 31536: Modifier -50 is never appropriate for 31536 — the larynx is a single midline structure; biopsies from both vocal cords at the same session are still a single microlaryngoscopy procedure reported once. When reporting 31536 alongside other same-session procedures, apply -51 to the lower-valued procedure code — not to 31536 if it carries the highest value at that session. Coders sometimes apply -51 to every code in a multi-procedure session without determining which code has the highest value and which codes should carry the modifier.
📎 Sources
AMA CPT 2025 Professional Edition · CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) and CMS 2026 MPFS Final Rule (CMS-1832-F) · CMS RVU26A Relative Value Files · NCCI Policy Manual Chapter 5 (Respiratory System — Larynx), CMS 2024-2025 · ICD-10-CM Official Guidelines for Coding and Reporting FY2025 — Section I.C.2 (Neoplasm Coding) and Section IV (Outpatient Coding Guidelines) · ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 — Section B3.4 (Biopsy Procedures) · AAPC Otolaryngology Coding Alert — “No Biopsy? Then Don’t Report 31536: Reader Question” (AAPC, March 2014) · AAPC Otolaryngology Coding Alert — “Keep This Laryngoscopy Primer on Hand for Distinguishing Three Procedure Codes” (AAPC, April 2013) · AAPC Otolaryngology Coding Alert — “Recognize Key Words to Bill Effectively for Laryngoscopy Procedures” (AAPC, September 2000) · AAO-HNS CPT for ENT: Laryngoscopy (American Academy of Otolaryngology - Head and Neck Surgery, reviewed February 2025) · PayerPrice — CPT 31536 Fee Schedule and Payer Reimbursement Reference (November 2025) · NIH VSAC Code Systems — CPT 31536 Descriptor Verification (NLM, 2018) · Coding for the Mouth, Throat and Neck Including the Thyroid — Laryngoscopy Section (AAPC Coding Resource, 2020) · Noridian Medicare JE Part B — MPFS Indicator Descriptors (Global Period, Bilateral Indicator, and Assistant Surgeon Reference)